Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_assertion description "[Aberrant methylation of TFPI-2 was also detected in 73% (102/140) of pancreatic cancer xenografts and primary pancreatic adenocarcinomas, was more likely in older patients with pancreatic cancer, and significantly correlated with progression of IPMNs (P=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_assertion evidence source_evidence_literature NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_assertion SIO_000772 15592528 NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_assertion wasDerivedFrom befree-2016 NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_assertion wasGeneratedBy ECO_0000203 NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.
- befree-2016 importedOn "2016-02-19" NP472414.RAlAFfarfCnZ6Qt238uCaCJH7W0vZMhSRH-jixv5GXHmE130_provenance.